Zdrowie i gospodarka · 14/10/1998

FDA Releases Draft Guidance for Developing Medical Imaging Drugs and Biologics

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop and submit medical imaging drugs and biologics for disease diagnosis, as well as radiopharmaceuticals for in vivo use, in accordance with the proposed regulations published in 1998.